Title:
FUSED HETEROARYL DERIVATIVE
Document Type and Number:
Japanese Patent JP3810017
Kind Code:
B2
Abstract:
PROBLEM TO BE SOLVED: To provide a medicinal composition useful as a phosphatidylinositol 3-kinase (PI3K) inhibitor and an anticancer agent and to provide a new compound having good PI3K inhibiting action and a cancerous cell growth inhibiting action.
SOLUTION: A bicyclic fused heteroaryl derivative or a salt thereof and a medicinal composition containing the fused heteroaryl derivative or the salt thereof and a pharmaceutically acceptable carrier are provided.
Inventors:
Masahiko Hayakawa
Hiroyuki Kaizawa
Hiroyuki Moritomo
Kenichi Kawaguchi
Tomonobu Koizumi
Mayumi Yamano
Mitsuyo Matsuda
Minoru Okada
Mitsuaki Ota
Hiroyuki Kaizawa
Hiroyuki Moritomo
Kenichi Kawaguchi
Tomonobu Koizumi
Mayumi Yamano
Mitsuyo Matsuda
Minoru Okada
Mitsuaki Ota
Application Number:
JP2004332225A
Publication Date:
August 16, 2006
Filing Date:
November 16, 2004
Export Citation:
Assignee:
Astellas Pharma Inc.
LUDWIG INSTITUTE FOR CANCER RESEARCH
Imperial Cancer Research Technology Limited
LUDWIG INSTITUTE FOR CANCER RESEARCH
Imperial Cancer Research Technology Limited
International Classes:
C07D239/94; A61K31/517; A61K31/5377; A61K31/541; A61P35/00; A61P43/00; C07D215/42; C07D401/04; C07D401/12; C07D403/04; C07D405/04; C07D405/12; C07D409/04; C07D409/12; C07D413/04; C07D471/04; C07D471/14; C07D487/04; C07D491/147; C07D495/04; C07D495/14; (IPC1-7): C07D215/42; A61K31/517; A61K31/5377; A61K31/541; A61P35/00; A61P43/00; C07D239/94; C07D401/04; C07D401/12; C07D403/04; C07D405/04; C07D405/12; C07D409/04; C07D409/12; C07D413/04; C07D471/04; C07D471/14; C07D487/04; C07D491/147; C07D495/04; C07D495/14
Domestic Patent References:
| JP2000505109A |
Foreign References:
| US5990117 |
Attorney, Agent or Firm:
Morita Taku
Emiko Yano
Emiko Yano